New Trial Date Set for VNUS Medical Technologies, Inc. Patent Litigation

SAN JOSE, Calif., Jan. 15 /PRNewswire-FirstCall/ -- The patent
infringement lawsuit brought by VNUS Medical Technologies, Inc. against three
endovenous laser competitors, Diomed, AngioDynamics and Vascular Solutions,
has been scheduled to start June 23, 2008. The jury trial is expected to last
three to four weeks. VNUS is seeking an injunction and compensatory damages
from the defendants. Judge Maxine Chesney of the U.S. District Court for the
Northern District of California set the June 23 trial date to allow sufficient
time for completion of a criminal case the judge is overseeing beginning
February 11, 2008.
ABOUT VNUS MEDICAL TECHNOLOGIES, INC.
VNUS Medical Technologies (Nasdaq: VNUS) is a worldwide leader in medical
devices for the minimally invasive treatment of venous reflux disease, a
progressive condition that causes the varicose veins afflicting 25 million
Americans. The pioneering company in the field, VNUS offers the ClosureFAST(R)
system, which consists of a proprietary radiofrequency (RF) generator and
proprietary disposable endovenous catheters and devices to close diseased
veins through the application of temperature-controlled RF energy. For more
information, please visit http://www.vnus.com.
FORWARD-LOOKING STATEMENTS
In addition to statements of historical facts or statements of current
conditions, VNUS has made forward-looking statements in this press release
regarding patent litigation. The reader is cautioned not to unduly rely on
these forward-looking statements. VNUS expressly disclaims any intent or
obligation to update these forward-looking statements except as required by
law.
SOURCE VNUS Medical Technologies, Inc.

Brian Farley, President and Chief Executive Officer of VNUS Medical
Technologies, +1-408-360-7499, ir@vnus.com